Test for Parkinson’s almost Here
Parkinson’s disease is a progressive neurological ailment that often manifests at the average age of 65, though there are cases of much younger people being diagnosed with the illness. Parkinson’s is called a movement disorder because of physical symptoms it typically manifests. However, pain can also become an issue over time; this along with depression, memory complications, and insomnia.
As with most illnesses, the sooner you are diagnosed with Parkinson’s and begin treatment, the more likely you are to live a relatively productive life. Of course, things are a little more complicated when it comes to Parkinson’s, primarily because diagnosing the disease at an early stage is hardly possible nowadays. There is no laboratory test that can allow physicians to detect the presence of Parkinson’s, especially during its earliest stages.
However, things may change soon as according to Doctor Alison Green of the National CJD Research and Surveillance Unit (University of Edinburgh), scientists might have made a breakthrough many medical experts have been looking for in their efforts to master new ways of diagnosing Parkinson’s.
According to Doctor Green, while this isn’t the first breakthrough to hit the medical arena with regards to diagnosing Parkinson’s, it is one of the few revelations that have shown real promise. Medical experts believe that they might have discovered a molecule that could be used to identify the disease in patients even before they manifest Parkinson’s symptoms.
A protein that forms sticky clumps in the brain cells of individuals with Parkinson’s, the molecule was discovered in the cerebrospinal fluid of patients with the illnesses. Upon learning to differentiate between the healthy and harmful forms of the protein, scientists observed the molecule not only in patients with the disease but also in people that were believed to be at risk of falling victim to Parkinson’s.
The hope is that patients with this molecule can be discovered in large enough numbers for scientists to pursue viable trials for new Parkinson’s treatments and medications. There is no cure for Parkinson’s but doctors believe there might be ways of slowing it down, though a cure is not so farfetched an idea. At the moment, doctors have to rely on medical history to discern the risk of Parkinson’s, this along with waiting for symptoms to emerge.
Doctor Green believes that the identification of this molecule could help unveil new and revolutionary methods of diagnosing Parkinson’s. No doubt, this breakthrough will bring hope to patients with Parkinson's that new, more effective treatment options might soon emerge.